Literature DB >> 33163561

GTPase Regulator Associated with Focal Adhesion Kinase 1 (GRAF1) Immunoglobulin-Associated Ataxia and Neuropathy.

Sean J Pittock1,2, Nora Alfugham1, Kevin O'Connor2, Shannon Hinson2, Amy Kunchok1,2, Vanda A Lennon1,2,3, Lars Komorowski4, Christian Probst4, Andrew McKeon1,2.   

Abstract

BACKGROUND: To date, 10 patients with GTPase Regulator Associated with Focal Adhesion Kinase 1/Rho GTPase Activating Protein 26-Immunoglobulin (GRAF1/ARHGAP26-IgG) associated neurological disorders have been described, most with ataxia.
OBJECTIVE: To report the clinical, oncological, and radiological associations of GRAF1 autoantibodies.
METHODS: We identified 17 patients whose serum and/or cerebrospinal fluid IgG was confirmed to target GRAF1/ARHGAP26-IgG by both tissue-based immunofluorescence and transfected cell-based assay. Clinical information was available on 14 patients.
RESULTS: The median age at neurological symptom onset was 51 years, and 8 (47%) were men. The predominant clinical features were subacute progressive cerebellar ataxia (13) or peripheral neuropathy (2). Magnetic resonance imaging brain (7 available) showed cerebellar atrophy (4, 1 also cerebrum and brainstem atrophy). Of 7 cerebrospinal fluids available for testing, 5 showed pleocytosis with oligoclonal bands in 3. Squamous cell carcinoma was observed in 3 patients (head and neck [2], lung [1]).
CONCLUSION: GTPase Regulator Associated with Focal Adhesion Kinase 1 autoimmunity manifests commonly with subacute ataxia and cerebellar degeneration with a potential association with squamous cell carcinoma. Peripheral neuropathy may also be encountered. Cases in this series responded poorly to immunotherapy.
© 2020 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  GTPase regulator, ataxia, neuropathy, tissue‐based immunofluorescence, paraneoplastic, GRAF1

Year:  2020        PMID: 33163561      PMCID: PMC7604666          DOI: 10.1002/mdc3.13036

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN: 2330-1619


  11 in total

1.  Psychotic syndrome associated with anti-Ca/ARHGAP26 and voltage-gated potassium channel antibodies.

Authors:  S Jarius; B Wildemann; W Stöcker; A Moser; K P Wandinger
Journal:  J Neuroimmunol       Date:  2015-07-22       Impact factor: 3.478

2.  From dizziness to severe ataxia and dysarthria: New cases of anti-Ca/ARHGAP26 autoantibody-associated cerebellar ataxia suggest a broad clinical spectrum.

Authors:  Ulrike Wallwitz; Sebastian Brock; Antje Schunck; Brigitte Wildemann; Sven Jarius; Frank Hoffmann
Journal:  J Neuroimmunol       Date:  2017-05-22       Impact factor: 3.478

3.  Anti-Ca/anti-ARHGAP26 antibodies associated with cerebellar atrophy and cognitive decline.

Authors:  Sarah Doss; Astrid Nümann; Annerose Ziegler; Eberhard Siebert; Kathrin Borowski; Winfried Stöcker; Harald Prüss; Brigitte Wildemann; Matthias Endres; Sven Jarius
Journal:  J Neuroimmunol       Date:  2013-11-06       Impact factor: 3.478

4.  A new Purkinje cell antibody (anti-Ca) associated with subacute cerebellar ataxia: immunological characterization.

Authors:  Sven Jarius; Klaus P Wandinger; Sigrun Horn; Heike Heuer; Brigitte Wildemann
Journal:  J Neuroinflammation       Date:  2010-03-12       Impact factor: 8.322

5.  Positron emission tomography-computed tomography in paraneoplastic neurologic disorders: systematic analysis and review.

Authors:  Andrew McKeon; Metha Apiwattanakul; Daniel H Lachance; Vanda A Lennon; Jayawant N Mandrekar; Bradley F Boeve; Brian Mullan; Bahram Mokri; Jeffrey W Britton; Daniel A Drubach; Sean J Pittock
Journal:  Arch Neurol       Date:  2010-01-11

6.  The endocytic protein GRAF1 is directed to cell-matrix adhesion sites and regulates cell spreading.

Authors:  Gary J Doherty; Monika K Åhlund; Mark T Howes; Björn Morén; Robert G Parton; Harvey T McMahon; Richard Lundmark
Journal:  Mol Biol Cell       Date:  2011-09-30       Impact factor: 4.138

7.  GRAF1 forms a complex with MICAL-L1 and EHD1 to cooperate in tubular recycling endosome vesiculation.

Authors:  Bishuang Cai; Shuwei Xie; Steve Caplan; Naava Naslavsky
Journal:  Front Cell Dev Biol       Date:  2014-05-27

8.  Involvement of Rho GAP GRAF1 in maintenance of epithelial phenotype.

Authors:  Miriam Regev; Helena Sabanay; Elena Kartvelishvily; Zvi Kam; Alexander D Bershadsky
Journal:  Cell Adh Migr       Date:  2016-09-02       Impact factor: 3.405

9.  Anti-ARHGAP26 Autoantibodies Are Associated With Isolated Cognitive Impairment.

Authors:  Frederik Bartels; Harald Prüss; Carsten Finke
Journal:  Front Neurol       Date:  2018-08-10       Impact factor: 4.003

10.  Two new cases of anti-Ca (anti-ARHGAP26/GRAF) autoantibody-associated cerebellar ataxia.

Authors:  Sven Jarius; Pedro Martínez-García; Adelaida León Hernandez; Jan Christoph Brase; Kathrin Borowski; Jens Ulrich Regula; Hans Michael Meinck; Winfried Stöcker; Brigitte Wildemann; Klaus-Peter Wandinger
Journal:  J Neuroinflammation       Date:  2013-01-15       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.